QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)
QQQ   358.01 (+0.84%)
AAPL   170.69 (+0.15%)
MSFT   313.64 (+0.27%)
META   303.96 (+2.09%)
GOOGL   132.31 (+1.36%)
AMZN   125.98 (+0.00%)
TSLA   246.38 (+2.44%)
NVDA   430.89 (+1.46%)
NIO   8.91 (+5.32%)
BABA   85.54 (-0.77%)
AMD   102.76 (+4.78%)
T   15.01 (+0.94%)
F   12.56 (+1.29%)
MU   65.20 (-4.41%)
CGC   0.81 (-8.95%)
GE   112.33 (+1.30%)
DIS   80.13 (+0.29%)
AMC   7.78 (+2.78%)
PFE   32.08 (-0.06%)
PYPL   58.18 (+1.46%)
NFLX   376.36 (-0.33%)

Walgreens Boots Alliance (WBA) Stock Forecast, Price & News

$20.90
-0.12 (-0.57%)
(As of 09/28/2023 ET)
Compare
Today's Range
$20.74
$21.22
50-Day Range
$20.90
$30.85
52-Week Range
$20.58
$42.29
Volume
7.29 million shs
Average Volume
8.54 million shs
Market Capitalization
$18.04 billion
P/E Ratio
N/A
Dividend Yield
9.19%
Price Target
$35.69

Walgreens Boots Alliance MarketRank™ Forecast

Analyst Rating
Hold
2.17 Rating Score
Upside/​Downside
70.8% Upside
$35.69 Price Target
Short Interest
Bearish
6.89% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.09
Upright™ Environmental Score
News Sentiment
0.46mentions of Walgreens Boots Alliance in the last 14 days
Based on 16 Articles This Week
Insider Trading
Acquiring Shares
$146,988 Bought Last Quarter
Proj. Earnings Growth
-4.75%
From $4.00 to $3.81 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.74 out of 5 stars

Retail/Wholesale Sector

44th out of 212 stocks

Drug Stores & Proprietary Stores Industry

2nd out of 4 stocks


WBA stock logo

About Walgreens Boots Alliance (NASDAQ:WBA) Stock

Walgreens Boots Alliance Inc. is a world-renowned healthcare, pharmacy, and retailing company. Founded in 1901 by John Boot and Charles R. Walgreen, the company has grown to become a leader in the industry, operating in nine countries and providing access to healthcare services to millions of people around the world. Walgreens Boots Alliance operates through three main segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.

The U.S. Retail Pharmacy segment includes the Walgreens business, which operates health and wellness services, retail drugstores, specialty and home delivery pharmacy services, and an equity method investment in AmerisourceBergen. Walgreens stores have locations in all 50 U.S. states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, offering access to consumer goods and services, pharmacy, photo department, and health and wellness services. Walgreens also operates online stores like Walgreens.com, Drugstore.com, VisionDirect.com, and Beauty.com.

The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution company in Germany. This segment includes the Boots brand, which has a history stretching back over 170 years in the United Kingdom, and stores in Ireland and Thailand with Boots franchise operations in the Middle East and Indonesia. The remainder of the division comprises Farmacias Ahumada (FASA) pharmacies in Chile and Benavides in Mexico. The Pharmaceutical Wholesale Division, including the Alliance Healthcare brand, supplied medicines and other healthcare products to more than 115,000  doctors, health centers,  pharmacies, and hospitals annually in eleven countries through 306 distribution centers. AmerisourceBergen purchased most of the Alliance Healthcare wholesale division in June 2021 for $6.275bn in cash.

The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omnichannel experience across the care journey. This segment includes the operation of 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics.

Walgreens Boots Alliance produces many brands, including Soltan and Botanics, Boots Pharmaceuticals, and Boots Laboratories, No. 7, that Alliance Boots and Walgreens sought to launch internationally following the first share purchase in 2012. These brands include the famous No. 7 beauty serums, developed in Nottingham, the UVA 5-star suncare protection by Soltan, and the Botanics range, developed in partnership with the Royal Botanic Gardens, Kew. Boots' brand range includes medicines, healthcare products, skincare, and many more. Walgreens also has a self-branded line of products called "Well at Walgreens."

For the fiscal year 2020, Walgreens Boots Alliance reported earnings of US$456 million. The reported revenue was US$139.5 billion, an increase of 2.5% over the previous fiscal cycle. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings. The company pays a Quarterly dividend of $0.48, representing an annual dividend yield of 5.08%. Wall Street analysts consider Walgreens stock to be Undervalued. 

Walgreens Boots Alliance has 862,503,540 shares outstanding, and its market cap is currently $31.99B. The company’s EPS estimate is $1.12, and its most recent earnings report saw it beat expectations with an EPS of $1.16. Following the earnings report, the stock price went down -6.135%. Among the most significant hedge funds holding Walgreens Boots Alliance’s shares is Antipodes Partners Ltd., which owns shares valued at $58M.

Walgreens Boots Alliance is a global healthcare leader committed to providing high-quality services and products to its customers. The company’s innovative strategies have earned it a reputation as a reliable and reputable partner for healthcare providers and consumers. With its wide array of products and services, Walgreens Boots Alliance is well-positioned to continue growing and meeting the needs of its customers for years to come.

WBA Price History

WBA Stock News Headlines

MarketBeat Week in Review – 8/28 - 9/1 (WBA)
The markets ended the week with mixed results as stocks enter what is historically the toughest month of the year and next week volume should pick up
Dell, Lululemon Athletica rise; Walgreens Boots Alliance, Olin fall, Friday, 9/1/2023
Stocks that traded heavily or had substantial price changes Friday: Dell, Lululemon Athletica rise; Walgreens Boots Alliance, Olin fall
Successful Options Trading Begins With…
Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!
Walgreens CEO exits less than 3 years after taking over drug store chain
The CEO of Walgreens Boots is stepping down after less than three years at the helm of the drug store chain
Does A 7.6% Dividend Make Walgreens A Better Buy Than CVS? (WBA)
These two high-potential healthcare names bring a rare opportunity for investors to gain some exposure to quality businesses trading at a discount to industry
Successful Options Trading Begins With…
Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!
Covid Boosters Aren’t Reaching People Who Want Them
Walgreens Boots Alliance (NASDAQ:WBA) PT Lowered to $27.00
Walgreens (WBA) New Study Shows Medical Adherence Importance
The Picture of Health
Walgreens: Don't Be Fooled - It's Cheap For A Reason
A Vitamin A Day
Walgreens Boots Alliance Stock: Bear vs. Bull
See More Headlines
Receive WBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Walgreens Boots Alliance and its competitors with MarketBeat's FREE daily newsletter.

WBA Company Calendar

Last Earnings
3/28/2023
Ex-Dividend for 9/12 Dividend
8/18/2023
Dividend Payable
9/12/2023
Today
9/28/2023
Next Earnings (Confirmed)
10/12/2023
Fiscal Year End
8/31/2024

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NASDAQ:WBA
CUSIP
93142210
Employees
325,000
Year Founded
2014

Price Target and Rating

Average Stock Price Forecast
$35.69
High Stock Price Forecast
$54.00
Low Stock Price Forecast
$27.00
Forecasted Upside/Downside
+70.1%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
12 Analysts

Profitability

Net Income
$4.34 billion
Pretax Margin
-4.26%

Debt

Sales & Book Value

Annual Sales
$132.70 billion
Cash Flow
$7.28 per share
Book Value
$33.98 per share

Miscellaneous

Free Float
712,190,000
Market Cap
$18.11 billion
Optionable
Optionable
Beta
0.69

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Stefano Pessina (Age 82)
    Exec. Chairman
    Comp: $111.25k
  • Ms. Ginger L. Graham (Age 67)
    Interim CEO & Director
    Comp: $100k
  • Ms. Ornella BarraMs. Ornella Barra (Age 70)
    Chief Operating Officer of International
    Comp: $3.11M
  • Mr. Manmohan Mahajan (Age 44)
    Interim Global CFO & Principal Financial Officer
  • Mr. Todd Heckman (Age 50)
    Interim Global Controller & Principal Accounting Officer
  • Mr. Hsiao Wang (Age 50)
    Sr. VP & Chief Information Officer
  • Mr. Gerald Gradwell (Age 55)
    Sr. VP of Investor Relations
  • Ms. Danielle Carim Gray (Age 44)
    Exec. VP & Global Chief Legal Officer
  • Ms. Beth A. Leonard
    Sr. VP & Chief Communications Officer
  • Ms. Holly May (Age 40)
    Exec. VP & Global Chief HR Officer













WBA Stock - Frequently Asked Questions

Should I buy or sell Walgreens Boots Alliance stock right now?

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last twelve months. There are currently 1 sell rating, 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" WBA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WBA, but not buy additional shares or sell existing shares.
View WBA analyst ratings
or view top-rated stocks.

What is Walgreens Boots Alliance's stock price forecast for 2023?

12 Wall Street research analysts have issued 12-month price objectives for Walgreens Boots Alliance's stock. Their WBA share price forecasts range from $27.00 to $54.00. On average, they predict the company's stock price to reach $35.69 in the next year. This suggests a possible upside of 70.1% from the stock's current price.
View analysts price targets for WBA
or view top-rated stocks among Wall Street analysts.

How have WBA shares performed in 2023?

Walgreens Boots Alliance's stock was trading at $37.36 on January 1st, 2023. Since then, WBA shares have decreased by 43.8% and is now trading at $20.98.
View the best growth stocks for 2023 here
.

When is Walgreens Boots Alliance's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 12th 2023.
View our WBA earnings forecast
.

How can I listen to Walgreens Boots Alliance's earnings call?

Walgreens Boots Alliance will be holding an earnings conference call on Thursday, October 12th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 647-362-9199 with passcode "8277955".

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) issued its quarterly earnings results on Tuesday, March, 28th. The pharmacy operator reported $1.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.06. The pharmacy operator earned $34.86 billion during the quarter, compared to analysts' expectations of $33.56 billion. Walgreens Boots Alliance had a negative net margin of 2.44% and a positive trailing twelve-month return on equity of 12.62%. Walgreens Boots Alliance's quarterly revenue was up 3.3% compared to the same quarter last year. During the same period last year, the company earned $1.59 earnings per share.
Read the conference call transcript
.

How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?

Walgreens Boots Alliance declared a quarterly dividend on Wednesday, July 12th. Stockholders of record on Monday, August 21st will be given a dividend of $0.48 per share on Tuesday, September 12th. This represents a $1.92 annualized dividend and a dividend yield of 9.15%. The ex-dividend date of this dividend is Friday, August 18th.
Read our dividend analysis for WBA
.

Is Walgreens Boots Alliance a good dividend stock?

Walgreens Boots Alliance (NASDAQ:WBA) pays an annual dividend of $1.92 per share and currently has a dividend yield of 9.09%. WBA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for WBA.

What guidance has Walgreens Boots Alliance issued on next quarter's earnings?

Walgreens Boots Alliance updated its FY 2023 earnings guidance on Friday, September, 1st. The company provided earnings per share guidance of $4.00-$4.00 for the period, compared to the consensus estimate of $4.00. The company issued revenue guidance of -.

What is Stefano Pessina's approval rating as Walgreens Boots Alliance's CEO?

4,267 employees have rated Walgreens Boots Alliance Chief Executive Officer Stefano Pessina on Glassdoor.com. Stefano Pessina has an approval rating of 32% among the company's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Pfizer (PFE) and Exxon Mobil (XOM).

What is Walgreens Boots Alliance's stock symbol?

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (7.76%), State Street Corp (6.46%), Capital World Investors (2.27%), Geode Capital Management LLC (1.83%), Northern Trust Corp (0.90%) and Camber Capital Management LP (0.87%). Insiders that own company stock include John Patrick Driscoll, Kevin M Ban, Marco Patrick Anthony Pagni, Nancy M Schlichting, Rosalind G Brewer and Walgreens Boots Alliance, Inc.
View institutional ownership trends
.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Walgreens Boots Alliance's stock price today?

One share of WBA stock can currently be purchased for approximately $20.98.

How much money does Walgreens Boots Alliance make?

Walgreens Boots Alliance (NASDAQ:WBA) has a market capitalization of $18.11 billion and generates $132.70 billion in revenue each year. The pharmacy operator earns $4.34 billion in net income (profit) each year or ($3.84) on an earnings per share basis.

How many employees does Walgreens Boots Alliance have?

The company employs 325,000 workers across the globe.

Does Walgreens Boots Alliance have any subsidiaries?
The following companies are subsidiares of Walgreens Boots Alliance: Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, Bond Drug Company of Illinois LLC, Boots Opticians Professional Services Limited, Boots Properties Limited, Boots Property Partnerships, Boots Retail (Ireland) Limited, Boots Retail (Thailand) Limited, Boots UK Limited, Duane Reade, Farmacias Benavides S.A.B. de C.V., Innovation Associates Inc, Liz Earle Beauty, Prime Therapeutics Specialty Pharmacy LLC, Shields Health Solutions, Sinopharm Holding GuoDa Drug Store Co., Superior Acquisitions Limited, Superior Holdings Limited, Superior Luxco 1 S.à r.l., Take Care Health Employer Solutions, The Boots Company PLC, WBA Acquisitions UK Holdco 7 Limited, WBA Acquisitions UK Topco Limited, WBA Financial LLC, WBA International Limited, WBA Investments Inc., WBA Luxembourg 6 S.à r.l., WBA Luxembourg 7 S.à.r.l., WBAD Holdings Limited, Walgreen Arizona Drug Co., Walgreen Co., Walgreen Eastern Co. Inc., Walgreen International S.à r.l., Walgreen Investments Luxembourg S.à r.l., Walgreen Louisiana Co. Inc., Walgreen of Puerto Rico Inc., Walgreens Boots Alliance (Hong Kong) Investments Limited, Walgreens Boots Alliance Holdings LLC, Walgreens Boots Alliance Limited, Walgreens Specialty Pharmacy LLC, and Waltrust Properties Inc..
Read More
How can I contact Walgreens Boots Alliance?

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The official website for the company is www.walgreensbootsalliance.com. The pharmacy operator can be reached via phone at (847) 315-3700, via email at investor.relations@wba.com, or via fax at 847-914-2804.

This page (NASDAQ:WBA) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -